Sunday, November 22, 2026

Asthma vaccine effective in animal trials

French researchers have developed a vaccine that could induce long-term protection against allergic asthma, Medical Xpress reports. Their research on mice has been published in the journal Nature Communications. A team from Inserm, Institut Pasteur, and the company NEOVACS, have developed a conjugate vaccine, called a kinoid, by coupling the recombinant cytokines IL-4 and IL-13 with a carrier protein called CRM197 (a non-pathogenic mutated form of the diphtheria toxin, used in many conjugate vaccines). The preclinical results (in animal models) show that this vaccine induces the sustained production of antibodies specifically directed against IL-4 and IL-13. Six weeks after the first injection of the conjugate vaccine, 90% of the mice presented high levels of antibodies. Over one year after primary immunization, 60% of them still had antibodies capable of neutralizing IL-4 and IL-13 activity.

 

https://medicalxpress.com/news/2021-05-asthma-vaccine-effective-mice.html

BIG Media
BIG Media
Our focus is on facts, accurate data, and logical interpretation. Our only agenda is the truth.
spot_img

BIG Wrap

Xi-Putin-Trump summit could be seen as a win for new world order

(CNN)  From an airy government villa in the hills of southern China on Thursday emerged an image, perhaps, for our times: the leaders of China,...

Russian missiles hit Polish territory amid major attack on Ukraine

(Al Jazeera Media Network) Security cameras captured the moment a suspected Russian missile struck Polish territory during an attack on Ukraine on Friday. Poland’s...